Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Thomsen MDT"'
Autor:
Thomsen MDT; PIP Adviser, Lyngby, Denmark., Knudsen LE; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2024 Mar 08; Vol. 11, pp. 1389438. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Autor:
Thomsen MDT; PIP Adviser, Lyngby, Denmark., Knudsen LE; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2023 Mar 16; Vol. 10, pp. 1159815. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).
Autor:
Thomsen MDT; PIP Adviser, Lyngby, Denmark.
Publikováno v:
Current therapeutic research, clinical and experimental [Curr Ther Res Clin Exp] 2019 Feb 13; Vol. 90, pp. 135-142. Date of Electronic Publication: 2019 Feb 13 (Print Publication: 2019).
Publikováno v:
Journal of Clinical Pharmacology; Jul2023, Vol. 63 Issue 7, p859-868, 10p
Publikováno v:
British Journal of Clinical Pharmacology; Oct2022, Vol. 88 Issue 10, p4250-4257, 8p
Autor:
Lizano‐Díez, Irene, Kargodorian, Joseph, Piñero‐López, M. Ángeles, Lastra, Cecilia F., Mariño, Eduardo L., Modamio, Pilar
Publikováno v:
Pharmacoepidemiology & Drug Safety; Mar2022, Vol. 31 Issue 3, p270-282, 13p
Autor:
Gilpin, Andrea, Bérubé, Sophie, Moore-Hepburn, Charlotte, Lacaze-Masmonteil, Thierry, Samiee-Zafarghandy, Samira, Rieder, Michael, Gruenwoldt, Emily, MacLeod, Stuart, Litalien, Catherine
Publikováno v:
Canadian Medical Association Journal (CMAJ); 8/8/2022, Vol. 194 Issue 30, pE1083-E1085, 3p
Autor:
Klaus Rose, Author
With the emergence of effective drugs and observed drug toxicities in babies, two mantras emerged: that children are therapeutic orphans, and that children are not small adults. US and EU laws demand pediatric studies as a condition for the approval
Autor:
Klaus Rose
Many parents of children with serious health problems may wonder why new medicines are initially not approved for minors and, if their condition is rare, why at the same time there is such pressure to enter any young person under 18 into drug trials.